Address: Beijing's xizhimen south street, xicheng district
The British garden 1 floor. Room 824
Zip code: 100035
Telephone: 010-58562339
Fax: 010-58562339
Email address: cngjzj@163.com
Web site (click on the url link directly left) :
http://www.cngjzj.com/
Blog (click on the url link directly left) :
http://blog.sina.com.Cn/CNGJZJ
To xizhimen south street, xicheng district building to the British garden route
L airport line 1
Take the airport shuttle from the airport, the dongzhimen station transfer to metro line 2 to xizhimen direction and get off at xizhimen station, from C outbound, go straight to the east 100 meters on the right side to xizhimen south street, north to walk to the t-junction namely to the British garden 1 floor downstairs.
L airport line 2
From the capital airport take airport bus to xidan, get off at no.22, take a taxi to xizhimen south street English garden 1 floor.
L bus subway near:
106 bus GuanYuan: 107 road, express way
Bus: xizhimen south road 387, 44 road, inner ring 800, 816 road, inner ring 820, 845 road
Che zhuang: subway line two
Xizhimen subway: metro line 2
Buses and attempts: 107 road, 118 road, 701 road
Buses and north zhuang: 209 road, 375 road, 392 road
Your position is：
Home >>
R&Dplatform >>
R&Dplatform
2013年07月08日
复制链接
打印
大 中 小
Renhe pharmaceutical holding hands domhke pharmaceutical is committed to product research and development of traditional Chinese medicine
HTTP: / / http://www.scol.com.cn
The 2013-07-04
Source: China
Renhe pharmaceutical evening announced on July 1,, the company will acquire yangling domhke maddison pharmaceutical co., LTD. (including its wholly owned subsidiary of ankang zhongke maddison natural pharmaceutical co., LTD., hereinafter referred to as "domhke pharmaceutical") 100% equity, total price 360 million yuan. Announcement of the main content for domhke pharmaceutical registered capital of 80 million yuan, business scope for tablet, capsule, granule, rubber soft paste, powder, paste, emplastrum, Chinese herbal medicine extracts the development, production and sales; Small medical equipment research, development, etc. Renhe pharmaceutical company, said an official with the operation, is conducive to enhance the level of the company's development and the innovation ability, to cultivate and reserve technology research and development talent, will have a positive impact on the sustainable development of company.
In recent years, renhe pharmaceutical companies continuing to pour money into research and development, implement the strategy of company development, market-oriented, combination process for technology innovation system construction, the use of external resources of science and technology continues to improve. The m&a action reflects the company on the development strategy of forward-looking.
According to understand, renhe pharmaceutical after buy domhke pharmaceutical shares, not only can expand Chinese medicine business for the company, also greatly enriched the company's products resources, to build a complete industrial chain of the stage. It is more advantageous to promote the science and technology content of the company's products. Believe renhe pharmaceutical pharmaceutical product development process in the future, will get unexpected results.
Renhe pharmaceutical co., said the acquisition, the company will further optimize the structure of pharmaceutical research and implement company to optimize the drug structure, and spare no effort to improve company's competitiveness and sustainable development ability.
The original link: http://focus.scol.com.cn/xxsd/content/2013-07/04/content_5559109.htm
(this site editor Wang Zhong one)
